drugset / Trial / NCT00002587

Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors

NCT00002587

Phase 1 Completed 20 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of paclitaxel plus topotecan in treating patients who have solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Timeline

Start
1994-09
Primary completion
2000-12
Completion
2000-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule Intravenous
Subject Topotecan Small molecule Intravenous